Back to Market Feed

Product Information

GAVILYTE-C SOLUTION is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.0039 per ML under NDC 43386006019. Its NADAC has been published 665 times since Nov 28, 2013.

FDA first approved this application on Jun 1, 2009.

Strength

240; 2.98; 6.72; 5.84; 22.72 g/278.26g; g/278.26g; g/278.26g; g/278.26g; g/278.26g

NDC

43386006019

Classification

Generic

Dosage Form

POWDER, FOR SOLUTION

Route

ORAL

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA090186

FDA Approved

6/1/2009

On Market Since

1/6/2009

Pharmacological Classes

Increased Large Intestinal Motility
Increased Large Intestinal Motility
Inhibition Large Intestine Fluid/Electrolyte Absorption
Inhibition Large Intestine Fluid/Electrolyte Absorption
Osmotic Activity
Osmotic Activity
Osmotic Activity
Osmotic Laxative
Osmotic Laxative
Osmotic Laxative
Potassium Compounds
Potassium Salt
Stimulation Large Intestine Fluid/Electrolyte Secretion

Price Statistics

The NADAC for GAVILYTE-C SOLUTION has been published 665 times since Nov 28, 2013, and over the history we have for it it has risen 58.4%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0039 per ML
All-time high$0.0042 (Jan 10, 2024)
All-time low$0.0022 (Jun 20, 2018)
52-week high$0.0039
52-week low$0.0036
Median price$0.0025
Average price$0.0028
Largest weekly change+43.1% (Aug 17, 2022)
Weeks tracked665
Tracking sinceNov 28, 2013

Price History

1W

+2.1%

1M

+2.1%

3M

+3.2%

6M

+1.9%

1Y

+6.1%

3Y

+10.0%

5Y

+51.0%

All

+58.4%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the polyethylene glycol-3350 and electrolytes with Flavor Pack market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

SODIUM CHLORIDE 0.9% IRRIG.
Generic
00264220100•B. Braun Medical Inc.
$0.0007
per ML
SODIUM CHLORIDE 0.9% IRRIG.
Generic
00264220110•B. Braun Medical Inc.
$0.0011
per ML
SODIUM CHLORIDE 0.9% IRRIG.
Generic
00338004747•Baxter Healthcare Corporation
$0.0014
per ML
SODIUM CHLORIDE 0.9% IRRIG.
Generic
00338004804•Baxter Healthcare Corporation
$0.0014
per ML
DEXTROSE 5%-0.45% NACL IV SOLN
Generic
00264761200•B. Braun Medical Inc.
$0.0015
per ML
DEXTROSE 5%-0.45% NACL IV SOLN
Generic
00338008503•Baxter Healthcare Corporation
$0.0015
per ML
DEXTROSE 5%-0.45% NACL IV SOLN
Generic
00338008504•Baxter Healthcare Corporation
$0.0015
per ML
SALINE 0.45% SOLN-EXCEL CON
Generic
00264780200•B. Braun Medical Inc.
$0.0019
per ML
SODIUM CHLORIDE 0.45% SOLN
Generic
00338004303•Baxter Healthcare Corporation
$0.0019
per ML
LACTATED RINGERS INJECTION
Generic
00338011704•Baxter Healthcare Corporation
$0.0020
per ML

Frequently asked questions

What is the NADAC price of GAVILYTE-C SOLUTION?

The current National Average Drug Acquisition Cost (NADAC) for GAVILYTE-C SOLUTION, manufactured by Lupin Pharmaceuticals Inc., is $0.0039 per ML (NDC 43386006019), effective Aug 19, 2026.

How has the price of GAVILYTE-C SOLUTION changed over time?

Over the history we have for it, the NADAC for GAVILYTE-C SOLUTION has risen 58.4%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for GAVILYTE-C SOLUTION?

Since Nov 28, 2013, the NADAC for GAVILYTE-C SOLUTION has ranged from a low of $0.0022 (Jun 20, 2018) to a high of $0.0042 (Jan 10, 2024), with a median of $0.0025 per ML.

Are there cheaper alternatives to GAVILYTE-C SOLUTION?

No other NADAC-published product currently shares the active ingredient and strength of GAVILYTE-C SOLUTION in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures GAVILYTE-C SOLUTION?

GAVILYTE-C SOLUTION (NDC 43386006019) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.